At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 100 target
Drug / intervention
Unfractionated heparin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
THE PRISM Study-Low-Molecular-Weight Heparin Versus Unfractionated Heparin for Perioperative Bridging Anticoagulation: the Patient Preference for Self-Injection Study and Related Measurements
In Brief
A Phase 4 clinical trial evaluating Unfractionated heparin and Enoxaparin for Bruises. Completed, enrolled 100 participants across 1 site.
Detailed Summary
The purpose of this study is to determine which short-acting blood thinner (low-molecular-weight heparin \[Enoxaparin\] or unfractionated heparin) is associated with less discomfort and bruising when given as a subcutaneous (under the skin) injection before and after a planned surgery or procedure in patients who temporarily stop warfarin.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBruises
CountriesCanada
CollaboratorsSt. Joseph's Health Care London
Timeline
Phase 4CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 2005
First PostedNov 2005
Study CompletionJan 2007
TodayJul 2026
First PostedNov 15, 2005
Enrollment StartOct 1, 2005
Study CompletionJan 1, 2007
TodayJul 2, 2026
Posted 20.6 years ago
Interventions
Unfractionated heparindrug
Enoxaparindrug